These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16574706)

  • 1. Alcohol alternatives--a goal for psychopharmacology?
    Ragan CI
    J Psychopharmacol; 2006 May; 20(3):325-6, discussion 331. PubMed ID: 16574706
    [No Abstract]   [Full Text] [Related]  

  • 2. "Alcohol alternatives: a goal for psychopharmacology?" by David J. Nutt.
    Cox WM
    J Psychopharmacol; 2006 May; 20(3):327-8, discussion 331. PubMed ID: 16574707
    [No Abstract]   [Full Text] [Related]  

  • 3. For alcohol alternatives, the science is not the hardest part.
    Room R
    J Psychopharmacol; 2006 May; 20(3):323-4, discussion 331. PubMed ID: 16574705
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulatory challenges in engineering a safer tipple.
    Hall W
    J Psychopharmacol; 2006 May; 20(3):321-2, discussion 331. PubMed ID: 16574704
    [No Abstract]   [Full Text] [Related]  

  • 5. Alcohol alternatives--a goal for psychopharmacology?
    Nutt DJ
    J Psychopharmacol; 2006 May; 20(3):318-20. PubMed ID: 16574703
    [No Abstract]   [Full Text] [Related]  

  • 6. Harm reduction: lessons learned from tobacco control.
    Munafò MR
    J Psychopharmacol; 2006 May; 20(3):329-30, discussion 331. PubMed ID: 16574708
    [No Abstract]   [Full Text] [Related]  

  • 7. Supply reduction's hidden casualties: a view from the trenches.
    Strathdee SA; Patterson TL
    Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337
    [No Abstract]   [Full Text] [Related]  

  • 8. Ecstasy versus alcohol: Tolstoy and the variations of unhappiness.
    Parrott AC
    J Psychopharmacol; 2007 Jan; 21(1):3-6; discussion 7. PubMed ID: 17213247
    [No Abstract]   [Full Text] [Related]  

  • 9. Rave drugs: pharmacological considerations.
    Hornfeldt CS
    AANA J; 2004 Oct; 72(5):334-5; author reply 335. PubMed ID: 15529726
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurobiologic principles of alcohol and drug dependence: dangerous learning mechanism].
    Hermann D; Nikitopoulos JA; Croissant B
    Pflege Z; 2004 Nov; 57(11):759-61. PubMed ID: 15587990
    [No Abstract]   [Full Text] [Related]  

  • 13. Supply control policy, harm reduction and context dependence.
    Weatherburn D
    Addiction; 2005 Jul; 100(7):927-8; discussion 930-2. PubMed ID: 15955006
    [No Abstract]   [Full Text] [Related]  

  • 14. A tale of two Es.
    Nutt DJ
    J Psychopharmacol; 2006 May; 20(3):315-7. PubMed ID: 16574702
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol problems and public health policy.
    Gordis E
    JAMA; 1997 Dec; 278(21):1781-2. PubMed ID: 9388159
    [No Abstract]   [Full Text] [Related]  

  • 16. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 17. Harm reduction--an ethical imperative.
    Van Beek I
    Addiction; 2009 Mar; 104(3):342-3; discussion 345-6. PubMed ID: 19207339
    [No Abstract]   [Full Text] [Related]  

  • 18. Harm reduction is now the mainstream global drug policy.
    Wodak A
    Addiction; 2009 Mar; 104(3):343-5; discussion 345-6. PubMed ID: 19207340
    [No Abstract]   [Full Text] [Related]  

  • 19. Harm reduction is a good label for a criterion all drug programs should meet.
    Maccoun RJ
    Addiction; 2009 Mar; 104(3):341-2; discussion 345-6. PubMed ID: 19207338
    [No Abstract]   [Full Text] [Related]  

  • 20. Intoxicating spin-offs.
    Anderson P
    Addiction; 2014 May; 109(5):699-700. PubMed ID: 24720821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.